Introduction
Methylation of cytosine-guanine dinucleotides (CpGs) on DNA is an important epigenetic mechanism involved in the selective regulation of gene expression and in the stabilization of chromatin. Therewith it is implicated in cell and tissue development and pathogenesis 1-3 such as cellular differentiation and cancer development, respectively. For example, it has been demonstrated that suppression of the pro-apoptotic gene Fas via promoter methylation is an essential mechanism for the generation of RAS transformed tumor cells. 4 Methylation of CpGs on DNA is achieved by DNA methyltransferases (DNMTs) whereby DNMT1 is associated with maintenance of global DNA methylation patterns and DNMT3a and DNMT3b are defined as de novo DNA methyltransferases. 5 Except a potential passive DNA demethylation during cell replication, for a long time CpG methylation markers were thought to be very stable. However, very recently groundbreaking insights have been published regarding the long-standing enigma of active DNA demethylation. In addition to findings of direct demethylation of cytosines, 6 conversion of 5-methyl-cytosine artificial induction of active DNa demethylation appears to be a possible and useful strategy in molecular biology research and therapy development. Dimethyl sulfoxide (DMsO) was shown to cause phenotypic changes in embryonic stem cells altering the genome-wide DNa methylation profiles. here we report that DMsO increases global and gene-specific DNa hydroxymethylation levels in pre-osteoblastic Mc3T3-E1 cells. after one day, DMsO increased the expression of genes involved in DNa hydroxymethylation (TET) and nucleotide excision repair (GaDD45) and decreased the expression of genes related to DNa methylation (Dnmt1, Dnmt3b, Hells). already 12 hours after seeding, before first replication, DMsO increased the expression of the pro-apoptotic gene Fas and of the early osteoblastic factor Dlx5, which proved to be Tet1 dependent. at this time an increase of 5-methyl-cytosine hydroxylation (5- DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells (5-mC) to 5-hydroxymethyl-cytosines (5-hmC) by members of the TET-hydroxylase gene family was shown to promote active DNA demethylation in mammalian cells through a process that requires the base excision repair pathway involving the GADD45 gene family. [7] [8] [9] [10] [11] [12] Further, it has been demonstrated that 5-hmC patterns are dynamically regulated during early embryonic differentiation and in mouse embryonic stem cells (ESC). 13 Tet1 is specifically expressed in murine ESC where it is required for stem cell maintenance by promoting the transcription of pluripotency factors. 14 These studies suggested for the first time a naturally occurring way for dynamic regulation of DNA methylation.
Dimethyl sulfoxide (DMSO) alters the epigenetic DNA methylation profile of mouse embryoid bodies causing phenotypic changes in embryonic stem cells by stimulation of Dnmt3a 15 and affect differentiation in several cell-lines. [16] [17] [18] [19] [20] Furthermore, a direct and specific stimulatory effect of DMSO on the catalytic activity of DNMT3a has been demonstrated in vitro. 21 The effect of this epigenetic active compound on genes related to active DNA demethylation is unknown.
Osteoblasts, the bone forming cells, derive from mesenchymal stem cells. 22 Driven by transcription factors like Dlx5, [23] [24] [25] [26] [27] initially Using the MC3T3-E1 cell line we report the ability of DMSO to induce active DNA demethylation. We demonstrate that via CpG hydroxymethylation DMSO affects promoter methylation of Fas and Dlx5 as well as global methylation patterns. This has an impact on cell viability and, as suggested by genome wide mRNA expression analysis, this compound may induce matrix synthesis in MC3T3-E1 cells.
the pre-osteoblastic MC3T3-E1 cell line expresses a phenotype which forms several cell layers and synthesizes huge amounts of collagen type I (COL1A1, COL2A2) containing extra cellular matrix, 28, 29 which mineralizes at late differentiation stages. [30] [31] [32] Recently it was demonstrated that at late differentiation stages, DMSO enhances mineralization of the extra cellular matrix by the osteoblastic MC3T3-E1 cell line. 33 Figure 1 . Effect of DMsO on the mRNa expression of genes involved in active DNa demethylation. after 1 d, DMsO strongly induced the expressions of Tet1 (a) and Tet2 (B) in a concentration dependent manner. Expression of Tet3 was not affected at this time (c). concomitantly, for Gadd45b (D) and Gadd45g (E) at 2% of DMsO and for Gadd45a (F) already at 1% DMsO in culture medium a significant upregulation was measured. after 5 d the effect was depleted or reduced except for Tet3 (c) and Gadd45a (F). at this time expression of Tet3 was significantly increased when compared with day 1. an even stronger effect was seen for Gadd45a expression after 5 d. To analyze mRNa expressions, RNa was isolated and analyzed by qRT-pcR. Gene expressions were normalized to 18S rRNa. Treated probes are referred as fold change to untreated control (co). Results are represented as mean ± sD *p < 0.05, **p < 0.01, *** or +++ p < 0.001, n = 3. significances were calculated by one-way aNOVa (*) or by two-way aNOVa (+).
Effects of DMSO on the mRNA expression of Fas and Dlx5.
DNA methylation dependent regulation of the pro-apoptotic gene Fas in MC3T3-E1 has previously been shown in reference 34. Furthermore, Gadd45a dependent demethylation of the early osteoblastic differentiation factor Dlx5 has recently been demonstrated in reference 35. After 1 d of DMSO treatment, Fas expression was clearly dose-dependently upregulated. However, a significant inverse effect was observed after 5 d of treatment ( Fig. 3A) . Further, after 1 d of DMSO treatment, we also observed a strong and concentration dependent upregulation of Dlx5 (Fig. 3B ). After 5 d this effect on Dlx5 expression by DMSO disappeared (Fig. 3B) .
Time course of DMSO modulated gene expression. To narrow the timeframe of the expression of genes, which are suggested being involved in the active demethylation process, MC3T3-E1 cells were treated with 1% DMSO for 1, 2, 3, 3, 4, 5 and 10 d. Compared with controls, upregulation for Tet1 was significant on day 1 while on day 2 only a trend to stimulation was observed ( Fig. 4A) . Tet2 was significantly upregulated on day 1 and 2 ( Fig. 4B) . No regulation was found for Tet1 and Tet2 until day 10 ( Fig. 4A and B) . Similarly, Gadd45b was strongly upregulated only at day 1, with no significant regulation during the following
Results
DMSO simultaneously affects the mRNA expression of genes involved in active DNA demethylation and DNA methylation processes. qRT-PCR analyses have shown that DMSO, particularly after 1 day of treatment, strongly and dose dependently upregulated the mRNA expression of two members of the TEToncogene family Tet1 (Tet oncogene 1) and Tet2 (Tet oncogene 2) while no regulation was found at day 5 ( Fig. 1A and B) . Tet3, the third member of this family, was not regulated at day 1 but was expressed significantly higher at day 5 (Fig. 1C) .
At both time points, DMSO significantly increased expression of all members of the GADD45 (growth arrest and DNAdamage-inducible 45) family. While DMSO stimulated Gadd45b and Gadd45g expression at day 1 ( Fig. 1D and E) Gadd45a was higher expressed at day 5 compared with day 1 (Fig. 1F) .
At the same time the mRNA expression of Dnmt1, Dnmt3b and Hells was downregulated in a concentration dependent manner ( Fig. 2A-C) . At day 5, however, attenuation of the effect was observed for most of the listed genes ( Figs. 2 and 3) . Interestingly, only a marginal regulation of the mRNA expression of Dnmt3a could be observed at any time analyzed ( Fig. 2D) . showed a strong, DMsO-concentration dependent downregulation after 1 d of treatment. also if the repression of Hells was after 5 d similar to day 1 (c), for all three genes a general alleviation was observed at this time (a-c). No significant effects could be measured for Dnmt3a expression at these times (D). To analyze mRNa expressions, RNa was isolated and analyzed by qRT-pcR. Gene expressions were normalized to 18S rRNa. Treated probes are referred as fold change to untreated control (co). Results are represented as mean ± sD *p < 0.05, **p < 0.01, ***p < 0.001, n = 3. significances were calculated by one-way aNOVa.
methylation was found to be significantly increased when compared with controls ( Fig. 6F and right bars). At this time no effect on cytosine methylation was measured for the Dlx5 promoter ( Fig. 6G and H) .
DMSO increases global DNA hydroxymethylation and decreases global DNA methylation. Hydroxymethylation was quantified with a multiwell plate reader by measuring fluorescence of 5-hmC-antibody stained preparations. As shown in Figure 7A , already after 12 h of treatment, DMSO significantly increased global DNA hydroxymethylation in a concentration dependent manner; after 1 d of treatment this effect was even more pronounced ( Fig. 7B) , while on day 5 no significant difference was found ( Fig. 7C) . As consequence of DNA hydroxymethylation, we evaluated if active DNA demethylation occurred by DMSO treatment. For this purpose, cells were synchronized by serum depletion and subsequently treated for 12 h with DMSO. Indeed, already after 12 h of DMSO treatment and thus before first cell replication starts, a significant global demethylation of DNA could be observed and this effect became more evident after 1 d of treatment ( Fig. 7D) . Similar to Dnmt1 expression, the demethylating effect of DMSO was clearly attenuated after 5 d of treatment and significantly reduced when compared with day 1 (Fig. 7D) . Figure 8A -D, 5-hmC immunostaining after 12 h and 24 h of 1% DMSO treatment is shown. Compared with control ( Fig. 8A) , already after 12 h of treatment signals of 5-hmC were observable ( Fig. 8B) whereby the effect clearly increased after 1 d ( Fig. 8C) . Co-staining with DAPI showed the localization of the nuclei and demonstrated the signals of 5-hmCs in the nuclei (Fig. 8D) . Nuclear staining with DAPI, a dye which preferentially labels heterochromatic regions on the chromosomes, 36, 37 revealed that most of the hydroxymethylated spots were found outside of these regions, suggesting that DMSO induced hydroxymethylation occurs primarily in the culture time ( Fig. 4C) . For Dnmt1 a downregulation was found after 1 d of treatment to 18% while on day 2 only a trend to downregulation was observed. No regulation was seen until day 10 ( Fig. 4D ). DNMT1 protein expression was confirmed by immunoblotting ( Fig. 4E) .
Nuclear localization of methyl-cytosine hydroxylation by DMSO in MC3T3-E1 cells. In
The pro-apoptotic gene Fas (Fig. 5A ) and the early osteoblastic differentiation factor Dlx5 (Fig. 5B) were significantly upregulated during the first 3 d, however, while Dlx5 was still significantly increased on day 3, Fas lost significance at that time point. Both genes showed no difference in expression until day 10 ( Fig. 5A and B) .
Decreased promoter CpG methylation of Fas and Dlx5 is accompanied by increased DNA CpG hydroxymethylation after DMSO treatment. As Tet1 and Tet2 were upregulated and Dnmt1 expression was suppressed by DMSO, we examined DNA hydroxymethylation and DNA methylation on Fas and Dlx5 promoters after DMSO treatment. Already after 12 h of DMSO treatment, we measured a considerable increment of DNA 5-hydroxymethylation of CpGs of both Fas and Dlx5 promoters ( Fig. 6A-D , left bars). After 1 d, the effect increased slightly or remained in a comparable range as for the Dlx5 proximal promoter region ( Fig. 6A-D , middle bars). On day 5 no difference between treated and untreated cell were observed ( Fig.  6A -D, right bars). Inversely, to elevated hydroxymethylation, all fragments analyzed showed significantly decreased DNA methylation levels already after 12 h of DMSO treatment ( Fig.  6E-H , left bars). According to Fas and Dlx5 mRNA expressions (as shown in Fig. 3A and B , respectively), after 1 d of DMSO treatment all promoter-fragments analyzed showed still significant cytosine demethylation when compared with untreated control ( Fig. 6E-H , middle bars). A different methylation pattern was found after 5 d of DMSO-treatment: the Fas CpG island at -2.6 kb showed a slighter but still significant decrease in cytosine methylation by DMSO ( Fig. 6E) , however, in correlation with Fas mRNA repression ( Fig. 3A) at position -30 bp cytosine analysis (see Fig. 6 ), already after 12 h of 1% DMSO treatment a significant upregulation of Fas mRNA expression could be detected. A similar increment was measured after 1 d of treatment. However, knockdown of Tet1 or Tet2 mRNA expression by siRNA abrogated the stimulatory effect at both times measured ( Fig. 9A) . Similar effects were observed when Dlx5 mRNA expression was analyzed, although, stimulation of Dlx5 expression was significantly increased not until 1 d of treatment ( Fig. 9B) . In Figure 9C and D, the efficacy of Tet1 and Tet2 knockdown by siRNA transfection after 1 d of 1% DMSO treatment is demonstrated. Finally, after 1 d of gene-rich euchromatic chromatin. Co-labeling of DMSO treated cells with antibodies against 5-hmC and 5-mC demonstrated areas where only 5-hmCs (green) or 5-mCs (red) were localized ( Fig. 8E) . However, also double-labeled regions were found (yellow) suggesting the co-existence of both, modified and unmodified methyl-cytosines.
Tet1 and Tet2 are key players in DMSO dependent demethylation and upregulation of Fas and Dlx5. To assure the role of active DNA demethylation in DMSO induced Fas and Dlx5 upregulation, Tet1 and Tet2 mRNA expression was knocked-down by siRNA. In line with promoter methylation Tet1 was significantly upregulated on day 1 while on day 2 the upregulation showed only a tendency. No regulation was found until day 10 (a). Tet2 was significantly upregulated on the first both days but no regulation was found until day 10 (B). On the first day, Gadd45b was significantly upregulated (c), while Dnmt1 was significantly downregulated (D). No regulation was found during the further culture time. Downregulation of DNMT1 was also found at the protein level (E). To analyze mRNa expressions, RNa was isolated and analyzed by qRT-pcR. Gene expressions were normalized to 18S rRNa. Treated probes are referred as fold change to untreated control (co). Results are represented as mean ± sD *p < 0.05, **p < 0.01, ***p < 0.001, n = 3. significances were calculated by two-way aNOVa and Bonferroni post hoc test. activities were measured. DMSO, dose ( Fig. 11A) and time ( Fig. 11B ) dependently regulated cell multiplication of MC3T3-E1 cells. At the second day of treatment, at 0.5% DMSO in culture medium, cell multiplication was increased significantly whereby at 2% a significant attenuation was observed ( Fig. 11A) . Cell multiplication was more pronounced after 5 d of treatment and significantly decreased by both 1% and 2% of DMSO ( Fig. 11B) .
FAS directly activates caspase 8 and indirectly caspase 3 and 7. 38, 39 To verify the role of apoptosis in DMSO dependent attenuation of cell multiplication, caspase 8 and caspase 3/7 activities were measured after 1 d and after 5 d of DMSO treatment. In line with Fas expression (Fig. 3A) , after 1 d both DMSO concentrations significantly increased caspase 3/7 ( Fig. 11C ) and caspase 8 ( Fig. 11D) activities when compared with untreated controls. Furthermore, after 5 d of treatment the DMSO effect was clearly attenuated ( Fig. 11E and F) . Only at 2% DMSO in the culture medium a slight but significant increase of caspase 3/7 activity was still measured ( Fig. 11E) . Figure 12 shows the time course of cell multiplication during 10 d of culture ( Fig. 12A ) and compares the ratio between living and dead cells ( Fig. 12B) . At the beginning of the culture, the difference in cell number increases indicating increased apoptosis in DMSO treated cells; the higher ratio of dead to living cells ( Fig. 12B ) on culture start supports this assumption. With culture time, the difference between untreated and DMSO treated cells increased until day 5. Then the differenced disappeared and the ratio of dead cells to living cells went below 1 in DMSO treated cells, which indicates a higher survival/dead rate after 10 d in the treated cells when compared with control cells. This results support the findings of Fas expression and caspase activities ( Figs. 3A and 11C-F) . DMSO stimulates the expression of genes involved in ECM synthesis. Dlx5 is expressed at early stages during osteoblastic differentiation where ECM synthesis is induced. As shown in Table 1 gene array data analysis shows that DMSO upregulated the mRNA expression of both genes collagen type I, Col1a1 and Col1a2, after five days of treatment. Furthermore, Col5a1 and Col5a2 were considerably expressed and strongly upregulated by DMSO at both days measured. Of the enzymes involved in posttranslational collagen modifications, two of three known lysyl hydroxylases were expressed and upregulated by DMSO, especially Plod2 (procollagen lysine, 2-oxoglutarate-5-dioxygenase 2), which had been demonstrated to be essential in bone collagen fibril formation. 40 The gene coding for Lox, a protein, which crosslinks extracellularly the collagen I chains, is highly expressed and also upregulated by DMSO ( Table 1) . Furthermore, Mmp13, the 1% DMSO exposure, the effect of Tet1 and Tet2 knockdown was also visible on global 5-hmC status. Repression of Tet1 and Tet2 provoked a great attenuation of global 5-hmC levels when compared with cells treated only with DMSO ( Fig. 9E) . A diminution of 5-hmC labeled cells was also seen by immunestaining when 1% DMSO treated cells ( Fig. 10A) were compared with 1% DMSO/Tet1-siRNA treated MC3T3-E1 cells (Fig. 10B) . When compared with untreated control cells (see Fig. 8A ), the number of 5-hmC labeled cells was still higher in 1% DMSO/Tet1-siRNA treated cells.
DMSO affects cell multiplication and the activity of caspase 8 and caspase 3/7 in MC3T3-E1 pre-osteoblasts. As Fas expression was altered by DMSO, cell proliferation and caspase In Fas as well as in Dlx5 promoters cpG hydroxymethylation and methylation were affected by DMsO treatment. specific cpG hydroxymethylation (a-D) and cpG methylation (E-h) were measured in selected promoter regions of Fas and Dlx5 after treatment with 1% DMsO for the given periods. already after 12 h of treatment, a strong increase in 5-hmc status and a concomitant decrease in cpG methylation was seen in both genes in all promoter fragments analyzed (a-h). after 1 d, the increase of 5-hmc status became significant for all fragments analyzed (a-D). compared with 12 h, cpG demethylation decreased further in the cpG island of the Fas promoter at -2.6 kb from transcriptional start (E), remained unchanged in the Dlx5 distal promoter fragment (G) and slightly diminished in the Fas cpG island at -30 bp from the transcriptional start (F) and in the Dlx5 proximal promoter (h). after 5 d, the Fas promoter region at -2.6 kb still showed a significantly decreased cpG demethylation after DMsO treatment (E). however, the Fas promoter region at -30 bp even showed a highly significant increase in cpG methylation. No changes in cpG methylation status were observed for both Dlx5 promoter fragments after 5 d of treatment. Results are represented as mean ± sD *p < 0.05, **p < 0.01, ***p < 0.001, for all n = 3, all significances were calculated by student's t-test. to regulation of Dlx5 expression, Gadd45a dependent active demethylation has recently been demonstrated. 35 Recently, an active DNA-demethylation process has been shown by oxidative modification of 5-mCs to 5-hmCs by members of the TET gene family with further involvement of the GADD45 gene family, which is responsible for nucleotide and base excision repair (reviewed in refs. 1, 10 and 47-49). This mechanism was suggested for active DNA demethylation in Xenopus laevis oocytes 7 and in embryos of zebrafish. 8 In adult neuronal tissue (cortex, hippocampus) activation and demethylation of promoters of specific neuronal genes with concomitant upregulation of Gadd45b and Gadd45c has been demonstrated. 50 Promoter DNA methylation is achieved by DNMTs, a highly conserved gene family. Dnmt1 is related to maintenance of CpG methylation patterns during mitosis while Dnmt3a and Dnmt3b play a role in de novo DNA-methylation. 51 HELLS was shown to act as DNA methylation supporter by recruiting DNMT1 and DNMT3B to promoters. 52 Moreover, Hells has been shown to play an essential role in bone development. 53 Downregulation of these proteins results in passive DNA-demethylation leading to activation of gene transcription. DMSO strongly downregulated the expression of Dnmt1, Dnmt3b and Hells after most important osteoblastic metalloproteinase was upregulated at day 1 and strongly downregulated at day 5.
Discussion
DMSO, a polar aprotic solvent widely used in biological and medical applications, was found to regulate epigenetic mechanisms altering CpG methylation patterns in diverse cells and tissues 15, 41, 42 thus having an impact on their development and differentiation. 17 Here, we show that in pre-osteoblastic MC3T3-E1 cells DMSO significantly affects the expression of genes related to DNA hydroxymethylation and DNA methylation. This has consequences on the expression of Fas and Dlx5.
Expression of TET and GADD45 gene family members were significantly upregulated and genes involved in DNA methylation were significantly downregulated after 1 d of treatment with 1% DMSO. Furthermore, at this time the expression of the pro-apoptotic gene Fas and of the early osteoblastic differentiation factor Dlx5 was also increased by DMSO treatment. It has been demonstrated that epigenetic regulation of Fas expression via DNA methylation plays an important role in tumor development [43] [44] [45] [46] as well as in avoiding anoikis of osteoblasts. 34 In regard This is in contrast to recent reports, which have been performed in embryonic stem cells that have demonstrated rather an additive effect of both genes on 5-hmC formations. 54 However, in myeloid malignancies it has been demonstrated that despite an expression of wild type TET1 and TET3, an inactivating mutation of TET2 is sufficient to block active demethylation and thus to induce these diseases. [55] [56] [57] This suggests that TET1 or TET3 cannot replace the function of TET2.
In embryonic stem cells TET1 protein and 5-hmCs are enriched at regions with high density of CpGs around the TSSs 54,58,59 and requirement of Tet1 for active DNA demethylation in the adult mouse brain in vivo has been reported recently. There, after deamination of 5-hmC by the Aicda (AID, activation-induced deaminase)/Apobec (apolipoprotein B mRNA-editing enzyme complex) gene family, 5 hmUs are removed by base excision repair by Smug1 (single-strand-selective monofunctional uracil-DNA glycosylase 1) and Tdg (thymine-DNA glycosylase). 60 However, as found by genome wide expression analysis, in MC3T3-E1 cells these genes were either only weakly expressed or were downregulated by DMSO (Table S1) , in contrast to one day of treatment. Therefore, passive DNA demethylation of Fas and Dlx5 promoters is feasible. However, after seeding, MC3T3-E1 cells need at least 24-30 h for doubling and Fas as well as Dlx5 expression were already increased 12 h after seeding with concomitant DMSO treatment. Thus the data suggested an alternative mechanism for Fas and Dlx5 upregulation. Indeed, already after 12 h of treatment increased 5-hmC and decreased in 5-mC levels were measured on both, Fas and Dlx5 promoters and global 5-hmC levels were also significantly increased at this time suggesting active DNA demethylation. Furthermore, cell synchronization by serum depletion confirmed loss of DNA methylation by DMSO treatment before first cell replication cycle. A further argument for active DNA demethylation is that by DMSO induced global hydroxymethylation and Fas and Dlx5 upregulation could be prevented by Tet1-siRNA or Tet2-siRNA knockdown proving Tet1 and Tet2 involvement in this process. In our experiments, downregulation of either Tet1 or Tet2 was sufficient to attenuate upregulated Dlx5 and Fas and to prevent global hydroxymethylation. This suggests that in this case both gene products are a prerequisite for the demethylation process. to bone lining cells or to osteocytes; about two-thirds undergo apoptosis. 61 After 5 d of DMSO treatment Fas was downregulated and the effect on Dlx5 expression disappeared. However, at this time genes involved in synthesis of extra cellular matrix like Col1a1, Lox or Plod2 were upregulated. The heterogeneity of the pre-osteoblastic MC3T3-E1 cell line was previously shown in references 32 and 62. Considering these data, we interpret that DMSO initially induces a sub-population of MC3T3-E1 to apoptose. The surviving cells, possibly triggered by Dlx5, express genes related ECM synthesis that would generate greater amounts of collagenous ECM, which by a feedback mechanism supports osteoblastic survival 34 and constitutes the basis for an appropriate ECM mineralization. This suggestion fits with the recently published work by Stephens et al. where it was demonstrated that after long time exposure to DMSO (15 d), mineralization substantially increases in MC3T3-E1 cells. Interestingly, for this increased mineralization process, DMSO treatments during the first three days were crucial and sufficient, then the cultures lose their DMSO sensitivity (between day 3 and 6). 33 This unambiguously indicates that during the first culture period, future development of the cells is determined. Here we demonstrate that for this early culture period, the DMSO induced demethylation is limited in time. Timely coincidence strongly suggests that this DMSO induced demethylation is the trigger for the latter found increased mineralization of the culture, likely by increased collagen synthesis. Increased collagen synthesis could also be responsible for the convergence of the cell multiplication at day 10 and downregulation of Fas. ECM increases Cyclin A2 (Ccna2) expression and downregulates Fas by epigenetic promoter methylation 34 and takes over the regulation for the further differentiation of osteoblasts. 63 Reduced apoptosis and increased cell proliferation is also suggested by the decrease in the dead/live ratio at day 10.
As already mentioned above, on day 5 an increased methylation of Fas was found. This was found in parallel to a DMSO induced, although insignificant upregulation of Dnmt3a. This genes of the GADD45-family. Additionally, most members of the ERCC-family (excision repair cross-complementing rodent repair deficiency, complementation group), especially Ercc3, Ercc4 and Ercc5 (Xpg), were expressed and upregulated by DMSO (Table S1 ). These data suggest that instead of base excision repair, nucleotide excision repair is possibly responsible for continuing demethylation after hydroxymethylation in DMSO treated MC3T3-E1 cells.
In a very recent study, it has been shown that during osteoblastic differentiation of adipose-derived mesenchymal stem cells, GADD45A was upregulated and responsible for active demethylation of osteogenic genes with support of members of the ERCC gene family via nucleotide excision repair. 35 Here we show that expression of Gadd45a was continuously upregulated during culture time and stimulated by DMSO suggesting that a comparable demethylation process could occur driving further differentiation. Because this demethylation process proceeds via excision of methylated nucleotides (ERCC-driven), no hydroxymethylation will be found. Both genes are discussed for their role in nucleotide excision repair, the former by an ERCC-family mediated process, the latter by a TET-family mediated oxidative demethylation. 35, 47 However, DMSO also upregulated Gadd45b already at day one, but downregulated on day 5. This can be explained by the fact that respective cells have already undergone apoptosis as a consequence of promoter demethylation in the first 2 d of incubation.
Taken together, these findings suggest that DMSO, after Tet1 and/or Tet2 induced hydroxymethylation, finalizes active demethylation of Fas and Dlx5 promoters by nucleotide excision repair involving GADD45B. A second process of active demethylation for osteoblastic cells differentiation runs in parallel via ERCC-family and GADD45A.
In line with a very recent report in reference 13, we show that 5-hmCs were found solely in euchromatic regions of the chromatin suggesting that hydroxymethylation occurs mainly in euchromatin for the purpose of gene activation as shown for Dlx5 and Fas. Moreover, these findings indicate that either hydroxymethylation is specific for euchromatin or at least that DMSO regulates demethylation solely in transcribed chromatic areas. It has to be taken into account that 5-hmC levels were assessed by immune-staining techniques and the considerable difference measured between DMSO treated and control cells may be overestimated by the almost total absence of 5-hmCs labels in untreated cells.
The effect of DMSO on the expression of Fas provoked attenuation of cell multiplication and induction of apoptosis as shown by the initially increased caspases 3/7 and caspase 8 activities.
In parallel DMSO upregulated the early osteoblastic transcription factor Dlx5 suggesting stimulation of the early osteoblastic differentiation stage. [23] [24] [25] [26] [27] In vivo, osteoblasts differentiate either Mc3T3-E1 cells were treated for 1 d either with 1% DMsO without or with Tet1 si-RNa. Thereafter cells were fixed and incubate with anti-5-hmc antibody, followed by incubation with a fluorescence labeled secondary antibody. scale bar for all images is 50 μm. Furthermore, as Tet1 was shown to be required for ESC cell maintenance, 14 here it may be responsible for the presumed retention of an early ECM producing osteoblastic phenotype via Dlx5 by DMSO. However, a novel feature of this study is provided from data indicating that apoptosis can be regulated by active DNA demethylation, thus revealing a new approach for the understanding of cell death regulation. The role of DNA gene is obligatory for proper methylation during hematopoiesis 64 und has been found upregulated by DMSO in mouse embryoid body. 15 Furthermore, an enzymatic stimulation of Dnmt3a at higher concentrations was found in an in vitro assay. 21 One might speculate that an upregulation of Dnmt3a or a stimulation of the enzymatic activity could be responsible for Fas de novo methylation. Figure 11 . Effect of DMsO on cell multiplication and caspases 3/7 and caspase 8 activities after DMsO treatment. after 2 d of treatment with 0.5% DMsO in medium, cell multiplication was slightly but significantly increased while at 2% DMsO a significant decrease in cell multiplication was measured (a). cell multiplication was significantly attenuated after 5 d of treatment for both 1% and 2% of DMsO in medium (B). after 1 d, caspase 3/7 (c) as well as caspase 8 (D) activities were significantly upregulated at 1% as well as at 2% DMsO in culture medium when compared with untreated control (co). after 5 d treatment the activity of caspase 8 did not change significantly (F). caspases 3/7 were still increased at 2% DMsO while at 1% no significant difference was found (E) when compared with untreated control (co). Relative cell multiplication is expressed as μg DNa/well. caspases activities were measured by substrate cleavage and the generated luminescent signal was captured with a luminometer. Bars represent mean ± sD *p < 0.05, **p < 0.01, ***p < 0.001. For (a and B) n = 8, for all other graphs n = 5. significances were calculated by one-way aNOVa.
hydroxymethylation in osteoblastic differentiation has still to be elucidated.
In summary, the results presented assign new aspects to DMSO as epigenetic active drug. We show for the first time a chemical compound capable to induce methyl-cytosine hydroxylation, which results in active demethylation of Fas and Dlx5 promoters. This offers a role for DMSO as source for the development of compounds able to induce specific active demethylation of promoters, as in the past for the development of defined histone deacetylase inhibitors. 17 This could gain clinical importance for the therapy of diseases or/and for tumor treatment and help to understand physiological and pathophysiological mechanisms.
Materials and Methods
Cell culture. MC3T3-E1 cells, a clonal pre-osteoblastic cell line derived from newborn mouse calvaria (kindly donated by Dr. Kumegawa, Meikai University, Department of Oral Anatomy), were cultured in humidified air under 5% CO 2 at 37°C in α-minimum essential medium (α-MEM; Biochrom) supplemented with 5% fetal calf serum (Biochrom), 50 μg/mL ascorbic acid (Sigma), and 10 μg/mL gentamycin (Sigma). For propagation, cells were subcultured twice a week using 0.001% pronase E (Roche) and 0.02% EDTA in Ca 2+ -and Mg 2+ -free phosphatebuffered saline (PBS) before achieving confluence. To prevent a potential phenotypic drift during repeated sub-cultures the cells were not used more than 4 weeks after thawing.
For experiments, the cells were seeded in culture dishes at a density of 5,000/cm 2 and cultured for 12 h, 1, 2 and 5 d untreated as controls or in the presence of 0.5%, 1% or 2% of DMSO in culture medium. Cell synchronization was performed by serum starvation for 24 h. All cell experiments were performed in timeindependent triplicates, data are shown as mean of the three experiments.
Isolation of nucleic acids and expression analysis by qRT-PCR. DNA and RNA were extracted using a DNA/RNA Isolation Kit (Qiagen) following manufacturer's instructions. cDNA was synthesized from 0.5 μg RNA using the 1st Strand cDNA Synthesis Kit (Roche) as described by the supplier. The obtained cDNA was subjected to PCR amplification with a realtime cycler using FastStart SYBR-Green Master Mix (Roche) for the genes Dlx5, Fas, Tet1, Tet2, Tet3, Gadd45a, Gadd45b, Gadd45g, Dnmt1, Dnmt3a, Dnmt3b and Hells (primers are shown in Table 2A ). The qRT-PCR was performed with 45 cycles composed of 30 sec denaturation at 95°C, 30 sec annealing at the indicated temperature (Table 2A ) and 30 sec extension at 72°C after 10 min of initial denaturation at 95°C. For normalization of the expression we used the 18S RNA TaqMan probe (4319413E, Applied Biosystems). Expression was quantified using the comparative quantization method. 65 Affymetrix GeneChip analysis. Total RNA was isolated using a RNA Isolation Kit (Qiagen). Quality control of the RNA's as well as labeling, hybridization and scanning of the hybridized arrays was performed by the "Kompetenzzentrum fuer Fluoreszente Bioanalytik (KFB)" using the mouse 430 2.0 fragments were captured using the "MethylMiner Methylated DNA Enrichment Kit" (Invitrogen). In brief, methylated or hydroxymethylated DNA was captured by methyl-CpG binding domain protein 2 (MBD2) or by a specific hydroxymethyl-cytosine antibody (Abgent) respectively, coupled to magnetic beads to separate the unmodified from the non-modified DNA fractions. DNA was eluted from the magnetic beads with 200 μl of 2 M NaCl solution as single fraction independent from the CpG methylation density and concentrated by ethanol precipitation. Finally, the mean methylation or hydroxymethylation status of the fragments was determined by amplifying the fragments by quantitative real-time PCR. Amplification ratios of the bound (methylated/hydroxymethylated) DNA fraction to unbound (unmethylated/non-hydroxymethylated) DNA fraction were calculated (for primer design see Table 2B ).
For assessment of the specificity of the 5-hmC antibody, either 40 ng of non methylated, fully methylated or fully hydroxymethylated DNA standards (Zymo Research) were captured with the "MethylMiner Methylated DNA Enrichment Kit" in combination with the methyl-CpG binding domain protein 2 (MBD2) or with the hydroxymethyl-cytosine antibody (Abgent) as described above and eluted DNA fractions were chip (Affymetrix). Genes that were up or downregulated beyond 1.2-fold are listed in the Supplemental Data.
Specific promoter methylation and hydroxymethylation. To analyze the Fas and Dlx5 promoters DNA for 5-mC or 5-hmC, appropriate fragments of the targeted promoter regions were generated by digestion of 1 μg or of 7 μg of genomic DNA respectively with 70 U of the CpG methylation insensitive restriction enzyme MboII (Promega) for 1 h at 37°C from cells cultured for 12 h for 1 d or for 5 d with diverse concentrations of DMSO in the medium. Subsequently, the enzyme was heat inactivated at 65°C for 20 min. Two regions of the Fas promoter were selected. One CpG-rich region is localized at 2.6 kb and the second one at 30 bp upstream from the Fas transcriptional start site (TSS). 1, 4, 34 As shown in Figure 13 , of the Dlx5 promoter region, a fragment was selected with an overall CpG content of 51%. It starts at 1,049 bp upstream from the TSS and extends to 60 bp of the first exon. MboII digestion subdivided the selected promoter into two fragments: the distal region showed a CpG content of 47%, the proximal region of 55% ( Fig. 13 and NM_198854.1) . After MboII digestion, DNA was purified using a commercially available PCR clean-up Kit following the supplier's instructions. In the next step methylated or hydroxymethylated DNA Figure 13 . Dlx5 genomic structure with 5' flanking region (1,100 bp, black line), the non translated region (182 bp, light gray box), whose left border indicates the transcription start site, the first exon (355 bp, dark gray box) and a part of the first intron. The vertical bars above the horizontal line of the gene indicate the cpGs and the vertical lines labeled with M indicate the MboII restriction sites. Two fragments indicated by light gray arrows and labeled as distal and proximal fragments are used for the "MethylMiner" assay. using X-tremeGENE siRNA Transfection Reagent (Roche) as described by the supplier. One day after transfection, medium change was performed and one part of the cells was treated with medium containing 1% of DMSO while the other part was left unchanged. After an incubation time of 12 h and 1 d, nucleic acids were isolated as described above and subjected to qRT-PCR. Immunostaining of 5-hydroxymethyl-cytosine and 5-methyl-cytosine. After incubation with increasing DMSO concentrations for 12 h or 1 d, MC3T3-E1 cells were fixed by methanol-acetone (7:3) for 10 min at -20°C. For 5-hmC and 5-mC co-staining, cells were additionally incubated with 4 N HCl for 5 min at room temperature. After blocking, the cells for 20 min with 10% blocking reagent (Roche), cells were incubated for 1 h at room temperature with anti-5-hmC antibody (Abgent) or contemporaneously with anti-5-mC antibody (Eurogentec) both diluted 1:500 in blocking buffer. Afterwards, the cells were washed thrice with PBS and incubated for one further hour with Alexa488 or Alexa633 labeled secondary antibodies (Invitrogen) diluted 1:300 in blocking buffer. Finally nuclei were stained with Hoechst 33258 dye (Polysciences). The cell layers were washed several times with PBS and finally with water. Slides were mounted with Vectashield mounting media and immunofluorescence was visualized on a Leica laser-scanning microscope.
No signal was found by using only the Alexa488 or the Alexa633 labeled secondary antibody (Invitrogen).
Cell multiplication. MC3T3-E1 cells were seeded in culture dishes at a density of 5,000/cm 2 and were either left untreated (controls) or treated with 0.5%, 1% and 2% of DMSO in medium for 1, 2 and 5 d. For determination of the cell number (using DNA concentration as surrogate), cell layers were washed with PBS and frozen with 1 mM TRIS-HCl buffer (pH 8.0) containing 0.1 mM EDTA. During thawing, Hoechst 33258 dye (Polysciences) was added to a concentration of 1 μg/mL and, after an incubation time of 15 min at room temperature, the fluorescence was measured (excitation 360, emission 465 nm). 67 The amount of DNA was estimated using a standard curve prepared from calf thymus DNA (Roche).
Time course of cell multiplication was also measured by cell counting. For this purpose cells were seeded at a density of 5,000/cm 2 in 24-well culture plates and were either left untreated (controls) or treated with 1% of DMSO in medium for 1, 2, 3, 4, 5 and 10 d. After the respective culture time cells were detached by means of 1 ml 0.001% pronase E (Roche) and 0.02% EDTA in Ca 2+ -and Mg 2+ -free phosphate-buffered saline (PBS) and aliquots were counted with a cell counter (Casy).
Protein isolation and immunoblotting. For protein extraction, cell layers were washed two times with PBS and scraped in SDS sample buffer (2% SDS, 100 mM β-mercaptoethanol, 125 mM TRIS-HCl, pH 6.8) and heated at 95°C for 5 min. Thirty μg of protein extracts were fractionated on 8% SDSpolyacrylamide gels. Following SDS-gel electrophoresis, the proteins were transferred to nitrocellulose filters (Millipore) and blocked overnight with 10% blocking reagent (Roche Applied Science) in TN Buffer (50 mM Tris, 125 mM NaCl, pH 8). Subsequently, the filters were incubated for 1 h at room amplified by real-time PCR using the supplied PCR Primer (Fig. S1) .
Global DNA methylation. MC3T3-E1 cells were cultured either as described above or were synchronized by serum depletion for 1 d, to exclude DNA replication as cause for DNA demethylation. Subsequently the cells were treated with DMSO for 12 h. Thereafter cells were washed twice with PBS, detached with 0.02% Pronase in PBS and collected by centrifugation (1,400 rpm). Subsequently, DNA and RNA were isolated from about 5 × 10 5 cells with a DNA/RNA isolation Kit (Qiagen). Global methylation was addressed by digestion of DNA with the 5-methyl-cytosine sensitive restriction enzyme HpaII and compared with a restriction with the insensitive enzyme MspI. 66 100 ng DNA were digested in multi core buffer (Promega) with 5 U MspI or HpaII or incubated without enzyme (blank) for 3 h at 37°C in a total volume of 30 μl. Sticky ends of the DNA were filled up by adding 20 μl of a mixture containing 0.1 μM Biotin-11-dCTP and 0.1 μM Biotin-11-dGTP (Perkin Elmer) and 0.5 U Klenow-fragment of DNA-polymerase III (Promega) in 500 mM TRIS-HCl, pH 7.2, 100 mM MgSO 4 and 1 mM dithiothreitol and incubated at room temperature for half an hour. Thereafter, the reaction was transferred into multi-well plates (Optiplate, Beckman) and 100 μl of Reacti-Bind TM DNA Coating Solution (Pierce) was added to each well and incubated over night at room temperature. On the next day, the wells were washed once with TBS (10 mM Tris-HCL pH 8.0, 150 mM NaCl). After a blocking step with 1% blocking solution (Roche) in TBS for one hour, a solution of 50 ng/μl streptavidin-horse radish peroxidase conjugate (Promega) in TBS was added and incubated for one further hour at room temperature. Thereafter, the wells were washed three times with TBS containing 0.5% Tween-20 and two times with water. One hundred microliters of the chemo-luminescence substrate (Promega) was added to each well and the light emission was measured in an illuminometer (Promega).
Assessment of global cytosine 5-hydroxymethylation. After incubation with increasing DMSO concentrations for 12 h, 1 d or 5 d, MC3T3-E1 cells were fixed by methanol-acetone (7:3) for 10 min at -20°C. Thereafter cell layers were blocked for 20 min with 10% blocking reagent (Roche) and incubated for one further hour with 0.5 μg/ml anti-5-hmC antibody (Abgent). Afterwards, the cells were washed thrice with PBS and incubated for one further hour with an Alexa488 labeled secondary antibody (Invitrogen) diluted 1:300 in blocking buffer. Finally nuclei were stained with Hoechst 33258 dye (Polysciences). The fluorescence of both signals was measured with a multiwell plate reader (Tecan). The amount of DNA (nuclei signal) was estimated using a standard curve prepared from calf thymus DNA (Roche). The signal of the fluorescence of the 5-hmC staining was normalized to the amount of DNA. No signals were found when only the Alexa488 labeled secondary antibody (Invitrogen) was used.
Tet1 and Tet2 siRNA transfections. For Tet1 and Tet2 depletion by siRNA, MC3T3-E1 cells were seeded at 20,000 cells/cm 2 in six multi-well plates. Six hours after seeding, cells were transfected with 40 pmol of Tet1 or Tet2 siRNA (Sigma) Software) while p ≤ 0.05 was considered as significant. For each experiment, the triplicate results of the qRT-PCR were averaged and this mean value was treated as a single statistical unit. The data of the triplicate experiments are presented as means ± standard deviation (SD).
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